Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA.
about
Human cytomegalovirus mutant with sequence-dependent resistance to the phosphorothioate oligonucleotide fomivirsen (ISIS 2922)Antisense oligonucleotide inhibition of hepatitis C virus (HCV) gene expression in livers of mice infected with an HCV-vaccinia virus recombinantTreatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication.Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus ie1 mutant.Emerging antivirals for the treatment of hepatitis B.New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipientsUptake and antifungal activity of oligonucleotides in Candida albicans.Variables and strategies in development of therapeutic post-transcriptional gene silencing agentsEffective inhibition of human cytomegalovirus gene expression and replication by a ribozyme derived from the catalytic RNA subunit of RNase P from Escherichia coli.RNA interference-mediated targeting of human cytomegalovirus immediate-early or early gene products inhibits viral replication with differential effects on cellular functions.Bottlenecks in development of retinal therapeutic post-transcriptional gene silencing agentsRapid, cell-based toxicity screen of potentially therapeutic post-transcriptional gene silencing agentsImmediate-Early (IE) gene regulation of cytomegalovirus: IE1- and pp71-mediated viral strategies against cellular defensesRecent perspectives in ocular drug delivery.Advances in antisense oligonucleotide development for target identification, validation, and as novel therapeutics.Identification of cellular proteins that interact with human cytomegalovirus immediate-early protein 1 by protein array assay.Optical melting measurements of nucleic acid thermodynamics.Pre-mRNA mis-splicing of sarcomeric genes in heart failure.Human cytomegalovirus infection decreases expression of thrombospondin-1 independent of the tumor suppressor protein p53.A cellular high-throughput screening approach for therapeutic trans-cleaving ribozymes and RNAi against arbitrary mRNA disease targets.Antisense Oligonucleotide Mediated Splice Correction of a Deep Intronic Mutation in OPA1.Virucidal activity of a GT-rich oligonucleotide against herpes simplex virus mediated by glycoprotein B
P2860
Q24519013-C0ABF794-655D-4675-A883-F073129C239CQ28369580-EA0C9932-6DDD-4943-989B-6DD6BBCE8EDBQ30325785-B93ABEEC-8C32-4EF8-9F6B-19C33EEEF5CEQ33782001-87E12896-1BDC-4534-A206-945D14F32257Q33801328-408D3D11-AC9A-4C65-A823-78FBEC7E9BEBQ33812425-6E4C9308-EB04-4B26-844B-7550A7FE8E18Q34760610-E5C1F2A3-E86C-45EC-ACB6-968BF4EE9116Q35110219-AA8C227D-D623-43F8-AB8A-7662C4538A43Q35749594-9995ACBF-0828-445E-B7A7-A49CC18ABE14Q35943427-6935050A-2F13-484C-AC13-DA237CB148CBQ36071540-B9BF5800-1B2C-42BE-9F1C-E5534B4B11B7Q36073866-46E1FD7D-DEBC-4EBD-8F0F-CA8903F141F5Q36304265-94A7E9FF-8173-4F08-B951-057F7A7FCF7FQ37256549-6AF5DFC0-2665-4891-BBAE-7636F2CDA497Q37321859-2F388A67-06A0-4B53-8F8E-041BD7A2083FQ37566700-B458A4EA-B10F-45CE-AAFD-EB02128FE985Q37800199-63BE39F2-3D85-4A74-A46F-ECD5ABDFB8F3Q39003222-295BD1F3-86FE-4DD0-A78B-BB1A4CDADD55Q40943878-29CE6F4C-E835-41E9-8CF7-E4557EF178E2Q41641558-86D022DF-F1F0-4565-9E3F-8E35A585AE0EQ41787118-7407647C-24AB-4967-91A0-6E78C43E76B6Q42425029-71593C33-B829-4403-A642-157A84834157
P2860
Inhibition of human cytomegalovirus immediate-early gene expression by an antisense oligonucleotide complementary to immediate-early RNA.
description
1996 nî lūn-bûn
@nan
1996 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@ast
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@en
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@nl
type
label
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@ast
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@en
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@nl
prefLabel
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@ast
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@en
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@nl
P2093
P2860
P1476
Inhibition of human cytomegalo ...... entary to immediate-early RNA.
@en
P2093
P2860
P304
P407
P577
1996-09-01T00:00:00Z